Back to news

Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio

Globe Newswire18/09/202608:50 ET
0

Get started

Create a free account to read the full story and Whiz Insights.

Sign Up

Already have an account? Log in